Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2020-01-08 Director's Dealing
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2020-01-08 English
FORM 4
Director's Dealing
2020-01-08 English
FORM 4
Director's Dealing
2020-01-08 English
FORM 3
Director's Dealing
2020-01-06 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 30, 2019, reporting the appointment of a new Senior Vice President and Chief Financial Officer effective January 1, 2020. The key content is the announcement of a change in senior management, including details about the new officer's background and compensation. There are no financial statements or earnings data presented, nor is this a report of voting results or a regulatory certification. The primary focus is on management change, which aligns with the Board/Management Information category (MANG). The document length is 5932 characters, sufficient to contain substantive information about the management change rather than a brief announcement. Therefore, the appropriate classification is MANG with high confidence.
2019-12-30 English
Regulatory Filings 2019
Regulatory Filings Classification · 90% confidence The provided document text appears to be a large block of encoded or encrypted data without any readable content, titles, regulatory references, or financial information. There are no indications of specific report types, fiscal periods, or keywords that would allow classification into a specific financial filing category. Given the lack of identifiable content and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for miscellaneous or unclassifiable filings.
2019-12-20 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.